These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29745438)

  • 1. High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.
    Tsai SC; Sheu SY; Chien LN; Lee HC; Yuan EJ; Yuan RY
    Br J Clin Pharmacol; 2018 Sep; 84(9):2000-2009. PubMed ID: 29745438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Parkinsonism-Related Adverse Events and Associated Drugs in Korea.
    Kim S; Suh HS
    J Patient Saf; 2019 Dec; 15(4):e56-e59. PubMed ID: 28368965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide-induced parkinsonism.
    Sethi KD; Patel B; Meador KJ
    South Med J; 1989 Dec; 82(12):1581-2. PubMed ID: 2595431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe parkinsonism due to metoclopramide in a patient with polypharmacy].
    Hoogendam A; Hofmeijer J; Frijns CJ; Heeringa M; Schouten-Tjin a Tsoi SL; Jansen PA
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):175-7. PubMed ID: 11845569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe parkinsonism due to metoclopramide: the importance of early recognition].
    de Ronde MW; Kingma HJ; Munts AG
    Ned Tijdschr Geneeskd; 2013; 157(26):A6037. PubMed ID: 23835236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine related movement disorders: a nationwide population-based study.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Jan CF; Liaw YP
    Sci Rep; 2019 Feb; 9(1):1705. PubMed ID: 30737414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
    de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
    Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study.
    Wei CY; Tzeng IS; Lin MC; Yeh YH; Hsu CY; Kung WM
    Front Pharmacol; 2020; 11():433. PubMed ID: 32390831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrapyramidal adverse reactions to metoclopramide. A pharmacovigilance survey].
    Frez C; Awad Y; Sánchez N; Silva A; Mercado B; Marcotti C; Arévalo P; Apablaza K; Fernández P; Pérez D
    Rev Med Chil; 2018 Jul; 146(7):876-884. PubMed ID: 30534887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of fractures in subjects with antihypertensive medications: A nationwide claim study.
    Choi HJ; Park C; Lee YK; Ha YC; Jang S; Shin CS
    Int J Cardiol; 2015 Apr; 184():62-67. PubMed ID: 25697872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases.
    Indo T; Ando K
    Arch Neurol; 1982 Aug; 39(8):494-6. PubMed ID: 7103798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy.
    Grimes JD
    N Engl J Med; 1981 Dec; 305(23):1417. PubMed ID: 7300862
    [No Abstract]   [Full Text] [Related]  

  • 15. Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism.
    Lai CH; Yeh YC; Chen YY
    Ther Adv Drug Saf; 2019; 10():2042098619854007. PubMed ID: 31258887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide-induced parkinsonism and depression.
    Jibiki I; Maeda T; Yamaguchi N
    Acta Neurol (Napoli); 1992 Apr; 14(2):130-3. PubMed ID: 1414557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe parkinsonism due to metoclopramide in a patient with polypharmacy].
    Habets P
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1430-1. PubMed ID: 12174440
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.
    Miller LG; Jankovic J
    Arch Intern Med; 1989 Nov; 149(11):2486-92. PubMed ID: 2684075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects.
    Bauer M; Bamminger K; Pichler V; Weber M; Binder S; Maier-Salamon A; Tahir A; Jäger W; Haslacher H; Tournier N; Hacker M; Zeitlinger M; Langer O
    Clin Pharmacol Ther; 2021 Mar; 109(3):754-761. PubMed ID: 32966590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.